Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1.

Journal

Leukemia

ISSN: 1476-5551

Titre abrégé: Leukemia

Pays: England

ID NLM: 8704895

Informations de publication

Date de publication:
Jul 2020

Historique:

pubmed: 16 1 2020

medline: 16 1 2020

entrez: 16 1 2020

Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41375-020-0707-2 PMID: 31937894

pubmed: 31937894

doi: 10.1038/s41375-020-0707-2

pii: 10.1038/s41375-020-0707-2

doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

Pagination

1970

Commentaires et corrections

Type : ErratumFor

Auteurs

H Pfeifer (H)

Department of Medicine, Hematology/Oncology, Goethe-University, Frankfurt, Germany. h.pfeifer@em.uni-frankfurt.de.

G Cazzaniga (G)

Pediatric Clinic, University of Milan Bicocca, San Gerardo Hospital, Monza, Italy.

V H J van der Velden (VHJ)

Department of Immunology, Erasmus MC, University, Medical Center Rotterdam, Rotterdam, The Netherlands.

J M Cayuela (JM)

Hematology Laboratory and EA3518, University Hospital Saint-Louis, University Paris Diderot, Paris, France.

B Schäfer (B)

Kinderspital Zurich, Onkologie Diagnostik Labor, Zurich, Switzerland.

O Spinelli (O)

Hematology and Bone Marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo, Italy.

ORCID: 0000-0003-0374-1536

S Akiki (S)

Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK.

S Avigad (S)

Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

I Bendit (I)

Division of Hematology and Hemotherapy, Medical School, University of Sao Paulo, Sao Paulo, Brazil.

K Borg (K)

Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

H Cavé (H)

Department of Genetic Biochemistry, Hopital Robert Debre, Paris, France.

L Elia (L)

Department of Hematology, Laboratory of Molecular Biology, University La Sapienza, Roma, Italy.

S C Reshmi (SC)

Institute for Genomic Medicine, Nationwide Children's Hospital and the Ohio State University, Columbus, OH, USA.

G Gerrard (G)

Imperial Molecular Pathology, Centre for Hematology, Imperial College London, London, UK.

ORCID: 0000-0002-4614-227X

S Hayette (S)

Laboratory of Molecular Biology and UMR5239, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Benite, Lyon, France.

M Hermanson (M)

Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.

A Juh (A)

Division of Pediatric Hematology/Oncology, Department of Pediatrics, National University Hospital, Singapore, Singapore.

T Jurcek (T)

Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.

M C Chillón (MC)

Department of Hematology, University Hospital of Salamanca (IBSAL) & Cancer Research Centre-IBMCC, (Salamanca University-CSIC), Salamanca, Spain.

C Homburg (C)

Department of Experimental Immunhematology/Immuncytology, Sanquin Diagnostics, Amsterdam, The Netherlands.

G Martinelli (G)

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

V Kairisto (V)

TYKSLAB, Laboratory of Molecular Genetics, Turku University Hospital, Turku, Finland.

T Lange (T)

Abteilung fur Hamatologie und internistische Onkologie, Universitat Leipzig, Leipzig, Germany.

T Lion (T)

Childrens Cancer Research Institute, Labdia Labordiagnostik and Medical University, Vienna, Austria.

M C Mueller (MC)

III. Medizinische Klinik, Medizinische Fakultat Mannheim der Universitat Heidelberg, Mannheim, Germany.

F Pane (F)

Azienda Ospedaliera Universitaria Federico II di Napoli Universita, Naples, Italy.

L Rai (L)

Department of Hematology, Royal Free Campus, University College London, London, United Kingdom.

C Damm-Welk (C)

Department of Pediatric Hematology and Oncology, University Hospital, Justus Liebig University Giessen, Giessen, Germany.

T Sacha (T)

Hematology Department, Jagiellonain University Krakow, Krakow, Poland.

S Schnittger (S)

MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, Munich, Germany.

T Touloumenidou (T)

Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.

H Valerhaugen (H)

Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

P Vandenberghe (P)

Center for Human Genetics, University Hospital Leuven and KU Leuven, Leuven, Belgium.

J Zuna (J)

CLIP, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University and UH Motol, Prague, Czech Republic.

H Serve (H)

Department of Medicine, Hematology/Oncology, Goethe-University, Frankfurt, Germany.

E Herrmann (E)

Institut fur Biostatistik und Mathematische Modellierung, Goethe Universitat, Frankfurt, Germany.

S Markovic (S)